Knockdown of circ_PVT1 prevented LC progression via targeting miR-21-5p/CBX4 by inhibiting wnt4/β-catenin signal pathway, which could provide a novel therapeutic target for LC. The gene discussed is CBX4; the disease is laryngotracheoesophageal cleft.